Bariatric surgery may be recommended when excess weight leads to health issues such as type 2 diabetes, sleep apnoea, high blood pressure, or joint pain, and when lifestyle changes alone have not been enough.
Procedures such as sleeve gastrectomy and Roux‑en‑Y gastric bypass are carried out using minimally invasive keyhole surgery as part of a structured care pathway that includes dietetic, medical, and psychological support. These operations aim to achieve long‑term weight loss and improve obesity‑related health conditions.
For patients seeking non‑surgical solutions, we offer medical weight loss programmes that include GLP‑1 weight loss injections (such as Wegovy®, Ozempic®, and Saxenda®) and Endoscopic Sleeve Gastroplasty (ESG) — a scar‑free, incisionless procedure that reduces stomach volume.
We also provide a special combination therapy pathway, where modern research has shown that starting with weight loss medication before ESG — or using the two treatments together — can enhance results, improve early weight reduction, and support long‑term success. This tailored approach can be used as a standalone non‑surgical option or as a bridge to bariatric surgery when required.
ESG is a minimally invasive, non-surgical weight-loss procedure performed through the mouth, without cuts or scars. Using an endoscopic suturing device, the stomach is reshaped to reduce its volume, helping patients feel full sooner and eat less. ESG is suitable for selected individuals looking for effective weight loss with a shorter recovery time.
Copyright © 2025